XTRA.TO vs. NOVO-B.CO

Last updated Jun 9, 2026

XTRA.TO (Xtract One Technologies Inc) and NOVO-B.CO (Novo Nordisk A/S) are both stocks. XTRA.TO operates in Software - Application (Technology), while NOVO-B.CO operates in Biotechnology (Healthcare). Over the past 5 years, XTRA.TO returned -1.42%/yr vs 21.43%/yr for NOVO-B.CO. At a 0.04 correlation, their price movements are largely independent.

Performance

XTRA.TO vs. NOVO-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in Xtract One Technologies Inc (XTRA.TO) and Novo Nordisk A/S (NOVO-B.CO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

XTRA.TO is traded in CAD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, XTRA.TO achieves a -25.00% return, which is significantly lower than NOVO-B.CO's -13.26% return.

XTRA.TO

• 1D: 8.00%
• 1M: 14.89%
• YTD: -25.00%
• 6M: -16.92%
• 1Y: 14.89%
• 3Y*: -17.74%
• 5Y*: -1.42%
• 10Y*: —

NOVO-B.CO

• 1D: 0.00%
• 1M: -6.12%
• YTD: -13.26%
• 6M: -5.75%
• 1Y: -39.98%
• 3Y*: 6.65%
• 5Y*: 21.43%
• 10Y*: 17.35%

*Multi-year figures are annualized to reflect compound growth (CAGR)

XTRA.TO vs. NOVO-B.CO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
XTRA.TO Xtract One Technologies Inc	-25.00%	28.57%	-23.29%	46.00%	35.14%	-35.09%	-55.81%	-22.75%	24.63%
NOVO-B.CO Novo Nordisk A/S	-13.26%	-42.55%	-7.50%	207.46%	31.36%	64.88%	24.72%	27.56%	-0.53%

Correlation

The correlation between XTRA.TO and NOVO-B.CO is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.03
Correlation (5Y) Calculated over the trailing 5-year period	0.03
Correlation (All Time) Calculated using the full available price history since Jul 10, 2018	0.04

Return for Risk

XTRA.TO vs. NOVO-B.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XTRA.TO

XTRA.TO Risk / Return Rank: 51
XTRA.TO Sharpe Ratio Rank: 49
XTRA.TO Sortino Ratio Rank: 54
XTRA.TO Omega Ratio Rank: 53
XTRA.TO Calmar Ratio Rank: 49
XTRA.TO Martin Ratio Rank: 48

NOVO-B.CO

NOVO-B.CO Risk / Return Rank: 13
NOVO-B.CO Sharpe Ratio Rank: 10
NOVO-B.CO Sortino Ratio Rank: 13
NOVO-B.CO Omega Ratio Rank: 12
NOVO-B.CO Calmar Ratio Rank: 12
NOVO-B.CO Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XTRA.TO vs. NOVO-B.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtract One Technologies Inc (XTRA.TO) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XTRA.TO	NOVO-B.CO	Difference
Sharpe ratio: Return per unit of total volatility	0.19	-0.73	+0.91
Sortino ratio: Return per unit of downside risk	0.93	-0.80	+1.73
Omega ratio: Gain probability vs. loss probability	1.12	0.89	+0.23
Calmar ratio: Return relative to maximum drawdown	0.28	-0.74	+1.02
Martin ratio: Return relative to average drawdown	0.46	-1.12	+1.58
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XTRA.TO vs. NOVO-B.CO - Sharpe Ratio Comparison

The current XTRA.TO Sharpe Ratio is 0.19, which is higher than the NOVO-B.CO Sharpe Ratio of -0.73. The chart below compares the historical Sharpe Ratios of XTRA.TO and NOVO-B.CO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	XTRA.TO	NOVO-B.CO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.19	-0.73	+0.91
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.02	0.37	-0.39
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.39	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.15	0.71	-0.86

Drawdowns

XTRA.TO vs. NOVO-B.CO - Drawdown Comparison

The maximum XTRA.TO drawdown since its inception was -88.65%, which is greater than NOVO-B.CO's maximum drawdown of -74.84%. Use the drawdown chart below to compare losses from any high point for XTRA.TO and NOVO-B.CO.

Drawdown Indicators

	XTRA.TO	NOVO-B.CO	Difference
Max Drawdown Largest peak-to-trough decline	-88.65%	-74.84%	-13.81%
Max Drawdown (1Y) Largest decline over 1 year	-52.72%	-54.86%	+2.14%
Max Drawdown (3Y) Largest decline over 3 years	-67.01%	-74.84%	+7.83%
Max Drawdown (5Y) Largest decline over 5 years	-72.41%	-74.84%	+2.43%
Max Drawdown (10Y) Largest decline over 10 years	—	-74.84%	—
Current Drawdown Current decline from peak	-80.85%	-68.93%	-11.92%
Average Drawdown Average peak-to-trough decline	-68.24%	-11.59%	-56.65%
Ulcer Index Depth and duration of drawdowns from previous peaks	33.06%	35.85%	-2.79%

Volatility

XTRA.TO vs. NOVO-B.CO - Volatility Comparison

Xtract One Technologies Inc (XTRA.TO) has a higher volatility of 14.24% compared to Novo Nordisk A/S (NOVO-B.CO) at 11.01%. This indicates that XTRA.TO's price experiences larger fluctuations and is considered to be riskier than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XTRA.TO	NOVO-B.CO	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.24%	11.01%	+3.23%
Volatility (6M) Calculated over the trailing 6-month period	43.66%	40.60%	+3.06%
Volatility (1Y) Calculated over the trailing 1-year period	80.92%	55.67%	+25.25%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	72.79%	58.74%	+14.05%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	73.44%	45.48%	+27.96%

Dividends

XTRA.TO vs. NOVO-B.CO - Dividend Comparison

XTRA.TO has not paid dividends to shareholders, while NOVO-B.CO's dividend yield for the trailing twelve months is around 4.35%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NOVO-B.CO Novo Nordisk A/S	4.35%	3.58%	1.59%	1.01%	2.38%	2.54%	4.03%	4.22%	5.27%	4.54%	7.38%	2.50%
XTRA.TO Xtract One Technologies Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both XTRA.TO and NOVO-B.CO in my portfolio?

XTRA.TO and NOVO-B.CO have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.